Bayer is a research-based, growth-oriented global enterprise that plans to concentrate in future on its core competencies in the fields of health care, nutrition and innovative materials. It is therefore intended to place substantial parts of the existing chemicals and polymers activities into a new company called Lanxess, which is to be listed on the stock exchange by the beginning of 2005. The Bayer Group is committed to the principles of sustainable development with economic growth, ecological integrity and social responsibility accorded equal priority in its corporate activities throughout the world. In 2003, Bayer employed some 115,400 people and had sales of 28.6 billion. Capital expenditures amounted to 1.7 billion, R&D; expenses to 2.4 billion. For more information on Bayer go to



2004 CAER.CA